Bethany M Horne, Annisha A Attanayake, Kristian Aquilina, Tara Murphy, Charlotte P Malcolm
{"title":"Neurocognitive outcomes following postoperative paediatric cerebellar mutism syndrome: A systematic review.","authors":"Bethany M Horne, Annisha A Attanayake, Kristian Aquilina, Tara Murphy, Charlotte P Malcolm","doi":"10.1111/dmcn.16483","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To systematically review neurocognitive outcomes associated with postoperative paediatric cerebellar mutism syndrome (pCMS), comparing children with and without pCMS after posterior fossa tumour surgery, and in relation to moderating demographic and clinical risk factors.</p><p><strong>Method: </strong>PsycInfo, Medline, and Embase databases were systematically searched up to December 2024. Studies of children aged 2 to 18 years with pCMS who had undergone standardized neurocognitive assessment were included. Quality was appraised using Institute of Health Economics Quality Appraisal Checklist for Case Series and Quality In Prognosis Studies tools. Synthesis without meta-analysis was conducted.</p><p><strong>Results: </strong>Sixteen studies (n = 252 children presenting with pCMS, n = 590 without) met criteria for inclusion. Children who experienced pCMS were found to have pronounced, long-term neurocognitive impairments with severely affected processing speed, psychomotor and executive function, and poorer neurocognitive outcomes generally than children without pCMS. Current literature is limited by small samples, lack of diagnostic clarity or routine prospective screening of pCMS, and limited investigation of factors that may moderate neurocognitive outcomes.</p><p><strong>Interpretation: </strong>Children with pCMS have increased vulnerability to neurocognitive impairments which persist beyond the recovery of initial symptoms in the postoperative phase. Dedicated research is needed to further our understanding of the condition and moderators of neurocognitive outcomes to inform clinical care.</p>","PeriodicalId":50587,"journal":{"name":"Developmental Medicine and Child Neurology","volume":" ","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developmental Medicine and Child Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/dmcn.16483","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Aim: To systematically review neurocognitive outcomes associated with postoperative paediatric cerebellar mutism syndrome (pCMS), comparing children with and without pCMS after posterior fossa tumour surgery, and in relation to moderating demographic and clinical risk factors.
Method: PsycInfo, Medline, and Embase databases were systematically searched up to December 2024. Studies of children aged 2 to 18 years with pCMS who had undergone standardized neurocognitive assessment were included. Quality was appraised using Institute of Health Economics Quality Appraisal Checklist for Case Series and Quality In Prognosis Studies tools. Synthesis without meta-analysis was conducted.
Results: Sixteen studies (n = 252 children presenting with pCMS, n = 590 without) met criteria for inclusion. Children who experienced pCMS were found to have pronounced, long-term neurocognitive impairments with severely affected processing speed, psychomotor and executive function, and poorer neurocognitive outcomes generally than children without pCMS. Current literature is limited by small samples, lack of diagnostic clarity or routine prospective screening of pCMS, and limited investigation of factors that may moderate neurocognitive outcomes.
Interpretation: Children with pCMS have increased vulnerability to neurocognitive impairments which persist beyond the recovery of initial symptoms in the postoperative phase. Dedicated research is needed to further our understanding of the condition and moderators of neurocognitive outcomes to inform clinical care.
期刊介绍:
Wiley-Blackwell is pleased to publish Developmental Medicine & Child Neurology (DMCN), a Mac Keith Press publication and official journal of the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) and the British Paediatric Neurology Association (BPNA).
For over 50 years, DMCN has defined the field of paediatric neurology and neurodisability and is one of the world’s leading journals in the whole field of paediatrics. DMCN disseminates a range of information worldwide to improve the lives of disabled children and their families. The high quality of published articles is maintained by expert review, including independent statistical assessment, before acceptance.